This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Yunnan University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 3,363 
1 out of 14 Years Active: 2022
Title: Yiming Li: Innovator in HIV-1 Inhibition
Introduction
Yiming Li is a notable inventor based in Kunming, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds aimed at combating HIV-1.
Latest Patents
Yiming Li holds a patent for a DACOS-type NNRTIs amino acid ester derivative, which includes a preparation method, pharmaceutical composition, and its applications. This innovative compound is designed to serve as an HIV-1 inhibitor and can be utilized in the preparation of drugs for treating and preventing immunodeficiency viruses.
Career Highlights
Throughout his career, Yiming Li has worked with prestigious institutions such as Yunnan University and the Chinese Academy of Sciences. His research and development efforts have focused on creating effective pharmaceutical solutions to combat viral infections.
Collaborations
Yiming Li has collaborated with esteemed colleagues, including Yanping He and Hongbin Zhang, to advance his research and innovations in the field of pharmaceuticals.
Conclusion
Yiming Li's work in developing the DACOS-type NNRTIs amino acid ester derivative highlights his commitment to addressing critical health challenges. His contributions to HIV-1 inhibition represent a significant step forward in pharmaceutical research and development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile